Athenex, Inc.
USD0.20
+0.00 (+0.00%)
CEO
Yiu-Nam Lau F.R.C.P.,
IPO Date
2017-06-14
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.22
Prev. Close
$0.20
Day Low
$0.20
Day High
$0.20
52W Low
$0.08
52W High
$23.80
Market Cap
$0.00B
Volume
1.75M
| 8,382 |
| $1.36 |
| 24 Apr 2023 | Davis Stephanie A | director | A-Award | Acquired | 3,642 | $1.30 |
| 24 Apr 2023 | Fok Manson | director | A-Award | Acquired | 5,747 | $1.30 |
| 24 Apr 2023 | Kwan Rudolf | EVP, Chief Medical Officer | A-Award | Acquired | 3,755 | $1.30 |
| 24 Apr 2023 | WU JINN | director | A-Award | Acquired | 6,513 | $1.30 |
| 24 Apr 2023 | LAU JOHNSON YIU NAM | director, officer: CEO and Chairman of the Board | A-Award | Acquired | 8,736 | $1.30 |
| 24 Apr 2023 | Spiegel Robert J. | director | A-Award | Acquired | 2,300 | $1.30 |
| 24 Apr 2023 | VIERLING JOHN | director | A-Award | Acquired | 6,513 | $1.30 |
| 24 Apr 2023 | TSANG Benson Kwan Hung | director | A-Award | Acquired | 8,813 | $1.30 |